Unity Biotechnology, Inc. (UNBX)
OTCMKTS
· Delayed Price · Currency is USD
0.0907
+0.0124 (15.84%)
At close: Aug 15, 2025
Unity Biotechnology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | - | - | - | 0.24 | 4.78 | - | Upgrade
|
| Revenue Growth (YoY) | - | - | - | -95.07% | - | - | Upgrade
|
| Cost of Revenue | 12.06 | 13.01 | 19.7 | 35.46 | 38.39 | 67.31 | Upgrade
|
| Gross Profit | -12.06 | -13.01 | -19.7 | -35.22 | -33.61 | -67.31 | Upgrade
|
| Selling, General & Admin | 15.7 | 15.46 | 18.77 | 20.45 | 23.06 | 24.03 | Upgrade
|
| Operating Expenses | 15.7 | 15.46 | 18.77 | 20.45 | 23.06 | 24.03 | Upgrade
|
| Operating Income | -27.76 | -28.47 | -38.47 | -55.67 | -56.67 | -91.33 | Upgrade
|
| Interest Expense | - | - | -2.45 | -3.56 | -3.18 | -1.29 | Upgrade
|
| Interest & Investment Income | 1.48 | 1.73 | 2.87 | 1.22 | 0.1 | 1.2 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.48 | 3.45 | 4.39 | 15.44 | -1.11 | -0.32 | Upgrade
|
| EBT Excluding Unusual Items | -24.8 | -23.29 | -33.66 | -42.57 | -60.85 | -91.75 | Upgrade
|
| Merger & Restructuring Charges | - | - | -0.6 | -1.9 | - | -2.63 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.5 | Upgrade
|
| Asset Writedown | -2.71 | -2.71 | -5.6 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.12 | 0.03 | Upgrade
|
| Pretax Income | -27.5 | -25.99 | -39.86 | -44.47 | -60.73 | -93.84 | Upgrade
|
| Earnings From Continuing Operations | - | -25.99 | -39.86 | -44.47 | -60.73 | -93.84 | Upgrade
|
| Net Income | -27.5 | -25.99 | -39.86 | -44.47 | -60.73 | -93.84 | Upgrade
|
| Net Income to Common | -27.5 | -25.99 | -39.86 | -44.47 | -60.73 | -93.84 | Upgrade
|
| Shares Outstanding (Basic) | 17 | 17 | 15 | 9 | 6 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 17 | 15 | 9 | 6 | 5 | Upgrade
|
| Shares Change (YoY) | 9.46% | 13.90% | 55.60% | 70.10% | 9.73% | 16.60% | Upgrade
|
| EPS (Basic) | -1.63 | -1.54 | -2.70 | -4.68 | -10.88 | -18.45 | Upgrade
|
| EPS (Diluted) | -1.63 | -1.54 | -2.70 | -4.68 | -10.88 | -18.45 | Upgrade
|
| Free Cash Flow | -22.04 | -20.87 | -37.1 | -52.51 | -45.26 | -78.98 | Upgrade
|
| Free Cash Flow Per Share | -1.31 | -1.24 | -2.51 | -5.53 | -8.11 | -15.53 | Upgrade
|
| Operating Margin | - | - | - | -23589.83% | -1184.47% | - | Upgrade
|
| Profit Margin | - | - | - | -18842.80% | -1269.34% | - | Upgrade
|
| Free Cash Flow Margin | - | - | - | -22250.00% | -945.97% | - | Upgrade
|
| EBITDA | -26.94 | -27.6 | -37.28 | -53.49 | -53.79 | -87.89 | Upgrade
|
| D&A For EBITDA | 0.82 | 0.87 | 1.18 | 2.18 | 2.88 | 3.45 | Upgrade
|
| EBIT | -27.76 | -28.47 | -38.47 | -55.67 | -56.67 | -91.33 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.